Effect of upadacitinib on extraintestinal manifestations in patients with moderately to severely active Crohn's disease

被引:0
作者
Wright, Emily K. [1 ,2 ]
Colombel, Jean-Frederic [3 ]
Hudesman, David [4 ]
Cao, Qian [7 ]
Ghosh, Subrata [8 ]
Reinisch, Walter [9 ]
Lacerda, Ana [5 ]
Dubcenco, Elena [5 ]
Doshi, Chirag [5 ]
Anyanwu, Samuel [5 ]
Feng, Tian [5 ]
Rubin, David [6 ]
机构
[1] St Vincents Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY USA
[4] NYU Langone Hlth, Div Gastroenterol, Ctr Inflammatory Bowel Dis, New York, NY USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[7] Zhejiang Univ, Sir Run Shaw Hosp, Ctr Inflammatory Bowel Dis, Coll Med,Dept Gastroenterol, Hangzhou, Peoples R China
[8] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[9] Med Univ Vienna, Clin Dept Gastroenterol & Hepatol, Vienna, Austria
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
25
引用
收藏
页码:159 / 160
页数:2
相关论文
共 50 条
[41]   Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease [J].
Walters, Thomas D. ;
Faubion, William A. ;
Griffiths, Anne M. ;
Baldassano, Robert N. ;
Escher, Johanna ;
Ruemmele, Frank M. ;
Hyams, Jeffrey S. ;
Lazar, Andreas ;
Eichner, Samantha ;
Huang, Bidan ;
Li, Yao ;
Thakkar, Roopal B. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) :967-975
[42]   Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease [J].
Ghosh, Subrata ;
Feagan, Brian G. ;
Parra, Rogerio Serafim ;
Lopes, Susana ;
Steinlauf, Adam ;
Kakuta, Yoichi ;
Joshi, Namita ;
Lee, Wan-Ju ;
Lacerda, Ana P. ;
Zhou, Qian ;
Xuan, Si ;
Kligys, Kristina ;
Shukla, Nidhi ;
Louis, Edouard .
JOURNAL OF CROHNS & COLITIS, 2024, 18 (11) :1804-1818
[43]   Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results From a Randomized Phase 3 U-EXCEL Study [J].
Loftus, Edward V. ;
Colombel, Jean-Frederic ;
Lacerda, Ana Paula ;
Peyrin-Biroulet, Laurent ;
D'Haens, Geert ;
Panaccione, Remo ;
Reinisch, Walter ;
Louis, Edouard ;
Chen, Minhu ;
Nakase, Hiroshi ;
Greenbloom, Susan ;
DuVall, George ;
Sanchez-Gonzalez, Yuri ;
Mohamed, Mohamed-Eslam ;
Rhee, Susan ;
Feng, Tian ;
Dubcenco, Elena ;
Panes, Julian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10) :S518-S518
[44]   MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE [J].
Rubin, David ;
Pollack, Paul ;
Hunter, Theresa ;
Shan, Mingyang ;
Chan, Lai-Shan ;
Deckard, Deanilee .
INFLAMMATORY BOWEL DISEASES, 2022, 28 :S14-S15
[45]   Extraintestinal manifestations of Crohn's disease: Which are the risk factors? [J].
Barreiro-De Acosta, M ;
Lorenzo-Gonzalez, A ;
Nunez-Pardo, C ;
Pena, A ;
Dominguez-Munoz, E .
GASTROENTEROLOGY, 2004, 126 (04) :A474-A474
[46]   EFFECTIVENESS OF USTEKINUMAB FOR MANAGEMENT OF EXTRAINTESTINAL MANIFESTATIONS OF CROHN'S DISEASE [J].
Aboubakr, Aiya ;
Battat, Robert ;
Galati, Jonathan S. ;
Ahmed, Waseem ;
Scherl, Ellen J. ;
Longman, Randy S. ;
Lukin, Dana J. .
GASTROENTEROLOGY, 2021, 160 (06) :S701-S701
[47]   MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE [J].
Rubin, David ;
Pollack, Paul ;
Hunter, Theresa ;
Shan, Mingyang ;
Chan, Lai-Shan ;
Deckard, Deanilee .
GASTROENTEROLOGY, 2022, 162 (03) :S14-S15
[48]   Effect of 104 Weeks of Mirikizumab Treatment on Inflammatory Bowel Disease Questionnaire Scores Among Patients With Moderately to Severely Active Crohn's Disease [J].
Sands, Bruce E. ;
Jairath, Vipul ;
Gibble, Theresa Hunter ;
Lin, Zhantao ;
Traxler, Kristina ;
Protic, Marijana ;
Hozak, Rebecca ;
Feagan, Brian G. ;
Armuzzi, Alessandro ;
Bossuyt, Peter .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10) :S809-S809
[49]   Effectiveness of Adalimumab for the Treatment of Extraintestinal Manifestations of Crohn's Disease [J].
Barreiro, Manuel ;
Lorenzo, Aurelio ;
Seoane, Montserrat ;
Dominguez-Munoz, Enrique .
GASTROENTEROLOGY, 2010, 138 (05) :S692-S692
[50]   Extraintestinal manifestations of Crohn's disease:: prevalence and related factors [J].
Repiso, A. ;
Alcantara, M. ;
Munoz-Rosas, C. ;
Rodriguez-Merlo, R. ;
Perez-Grueso, M. J. ;
Carrobles, J. M. ;
Martinez-Potenciano, J. L. .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2006, 98 (07) :510-513